No headlines found.
No press releases found.
No news found.
F/m Emerald Life Sciences Innovation ETF is an actively managed ETF that invests primarily in equity securities of life sciences companies. The fund selects investments based on breakthrough science and innovation, targeting unique growth opportunities across companies of any size. The Fund's investments include common and preferred stock, other investment companies, and depositary receipts. It may also invest in private placements, warrants, rights, and initial public offerings.
F/M Emerald Life Sciences Innovation ETF trades on the NASDAQ stock market under the symbol LFSC.
As of July 7, 2026, LFSC stock price climbed to $46.88 with 2,333 million shares trading.
LFSC has a market cap of $126.91 million. This is considered a Micro Cap stock.
LFSC has outperformed the market in the last year with a price return of +88.9% while the SPY ETF gained +20.8%. LFSC has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +33.3% and +10.6%, respectively, while the SPY returned +13.8% and +0.5%, respectively.
LFSC support price is $45.50 and resistance is $47.27 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LFSC shares will trade within this expected range on the day.
